Nuvo Pharmaceuticals Inc MRVFF

RE:RE:Rock - External Consultant?

[ronz]

To be real here, if they had of stopped the trial early due to the lack of an"allergic season" due to the weather conditions, the market would have likely punished the stock price anyways for having a delay in the completion of the phase II b process. They were damned if they did and damned if they didn't. However, by following through without even a glimmer of the weather scenario they encountered during the trial, they allowed the share price to move up over the Fall and Winter to extreme highs on the impending results that were imminent and therefor only the ones with that insight as to what the weather was like in Germany the previous Summer which caused an unfair circumstance for the investors in Nuvo, because as we all know it dropped like a stone once the results were released. Ity was the perfect storm for many investors who thought that the trial went off without a hitch because the company gave no indication of what was happening in Germany.
The drug itself deserves another oppertunity simply because it needs the chance to be effective.
You can't test a cancer drug in somebody if they dont have cancer. So why would you test an allergy drug on somebody who is not affected by allergies because the allergen isn't present at the time of the trial. It makes any and all results redundant.